Cargando…
Erlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI
We designed and synthesized novel theranostic nanoparticles that showed the considerable potential for clinical use in targeted therapy, and non-invasive real-time monitoring of tumors by MRI. Our nanoparticles were ultra-small with superparamagnetic iron oxide cores, conjugated to erlotinib (FeDC-E...
Autores principales: | Ali, Ahmed Atef Ahmed, Hsu, Fei-Ting, Hsieh, Chia-Ling, Shiau, Chia-Yang, Chiang, Chiao-Hsi, Wei, Zung-Hang, Chen, Cheng-Yu, Huang, Hsu-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105135/ https://www.ncbi.nlm.nih.gov/pubmed/27833124 http://dx.doi.org/10.1038/srep36650 |
Ejemplares similares
-
Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination
por: Ali, Ahmed Atef Ahmed, et al.
Publicado: (2016) -
Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells
por: Chen, Cheng-Wei, et al.
Publicado: (2011) -
Non-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systems
por: Chen, Yu-Cheng, et al.
Publicado: (2013) -
DNA-supramolecule conjugates in theranostics
por: Chen, Kun, et al.
Publicado: (2019) -
Conjugated polymer nanomaterials for theranostics
por: Qian, Cheng-gen, et al.
Publicado: (2017)